AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Company proceeds to phase II clinical trial of StreptAvax.(ID Biomedical Corp. )(Brief Article)

Vaccine Weekly

| May 22, 2002 | COPYRIGHT 2002 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

2002 MAY 22 - (NewsRx.com & NewsRx.net) -- ID Biomedical Corp. announced that it has been granted permission by the Biologics and Genetic Therapies Directorate of the Health Products and Foods Branch of Health Canada to conduct a phase II clinical trial of StreptAvax, ID Biomedical's vaccine for the prevention of infections caused by group A streptococcus. StreptAvax is the only vaccine of its kind being tested in human clinical trials.

Permission was granted based on results from the phase I clinical trial which showed that StreptAvax had a good safety profile and was well tolerated by healthy adult volunteers. Additionally, the phase I study showed that StreptAvax stimulated broad immune responses against the strains targeted by the vaccine.

StreptAvax is a multivalent recombinant vaccine developed to cover 26 serotypes of group A streptococcus. According to data obtained from the U.S. Centers for Disease Control and Prevention (CDC), these serotypes are believed to be responsible for causing the vast majority of ...

Related articles from newspapers, magazines, journals, and more
ID Biomedical announces clinical trial of StreptAvax(TM) fully enrolled.
Press release article from: PR Newswire September 24, 2001 700+ words
...24 /PRNewswire/ - ID Biomedical announced today that...TM). StreptAvax, ID Biomedical's vaccine for the...testing. The current clinical trial is evaluating the safety...vaccine in children. ID Biomedical expects to enroll children...
ID Biomedical initiates Streptavax(TM) Clinical Trial.
Press release article from: PR Newswire July 24, 2001 700+ words
...PRNewswire/ - ID Biomedical Corporation today...started a Phase I/II Clinical Trial of StreptAvax...clinical trials. The clinical trial will initially evaluate...this portion of the clinical trial, ID Biomedical expects children...
ID Biomedical Completes Enrollment of 1,000 Subjects for Pivotal Fluviral...
Press release article from: PR Newswire March 30, 2005 700+ words
...Holler, M.D., ID Biomedical's Chief Executive Officer. ID Biomedical is also conducting a similar clinical trial of Fluviral in Canada...review mechanisms. ID Biomedical and CBER have outlined a clinical trial program that will...
ID Biomedical Announces Positive Preliminary Results From Clinical Trial of...
Press release article from: PR Newswire January 7, 1999 700+ words
...PRNewswire/ -- ID Biomedical Corporation (IDB...preliminary results of the clinical trial of its rapid culture...308 samples tested. ID Biomedical President, Dr. Tony...Dr. Robert Bryan, ID Biomedical's Vice President...
ID Biomedical announces positive results from FluINsure(TM) clinical trial.
Press release article from: PR Newswire April 2, 2002 700+ words
...FirstCall/ - ID Biomedical Corporation announced...Company's Phase I Clinical Trial of FluINsure...with FluINsure, ID Biomedical's non- living...from the Phase I Clinical Trial will be presented by ID Biomedical's Chief Scientific...
ID Biomedical announces positive results from StreptAvax(TM) clinical trial;...
Press release article from: PR Newswire March 20, 2002 700+ words
...FirstCall/ - ID Biomedical Corporation...s Phase I Clinical Trial of StreptAvax...presentation of these clinical trial results. Anthony...M.D., ID Biomedical's Chief Executive...toxicities. These clinical trial results v
ID Biomedical Announces Positive Results from Phase II Clinical Trial of...
Press release article from: PR Newswire August 10, 2004 700+ words
...expanded Phase II Clinical Trial. - Key supportive...TSX - "IDB" ID Biomedical announced today...subject in the clinical trial has developed...will be used by ID Biomedical to approach...of the human clinical trial data of StreptAvax...
ID Biomedical announces strong nasal immune responses in FluINsure(TM) clinical...
Press release article from: PR Newswire July 8, 2002 700+ words
...FirstCall/ - ID Biomedical Corporation...s Phase I Clinical Trial of FluINsure...Affairs for ID Biomedical, said, "With...Data from the clinical trial will be presented...profile. About ID Biomedical ID Biomedical...
For more facts and information, see all results
©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA